Dr. Abasi Ene-Obong is a seasoned business leader and scientist with extensive experience in
the US, UK, and African healthcare and biotech industries. He is the founder and CEO of
Syndicate Bio, a health technology company building the world’s most diverse human health
datasets and applying AI/ML to power human discoveries and inclusive care globally. Abasi also
founded and was the CEO of 54gene, Inc., a pioneering African genomics company, and built a
biobank of 100K+ samples connected to clinical records in 2 years. This remains one of the largest
ethical and informed consented genomic resources of African samples globally. Earlier in his
career, Abasi was a management consultant for IQVIA and PwC, providing advisory services to
US life pharmaceutical companies.

Previously, Abasi worked as a research scientist and holds a PhD in Cancer Biology from the
University of London and an MSc in Human Molecular Genetics from the Imperial College London.
He is published in some of the world’s leading scientific journals, such as Gastroenterology, Cell,
Nature, and Cancer Discovery, and was invited by Nature Biotech, alongside Bill Gates, Jennifer
Doudna, and others, to co-author the “Voices of Biotech” issue. Dr Abasi has been featured in
leading magazines such as The Financial Times, Wired, and Time and has received many awards,
including Endpoints 20 under 40 and Fortune 40 under 40. Abasi also sits on multiple boards and
committees, including the American College of Medical Genetics’ International Outreach and
Engagement Committee and the Bloomberg New Economy International Cancer Coalition.